Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms.
Monsma DJ, Cherba DM, Eugster EE, Dylewski DL, Davidson PT, Peterson CA, Borgman AS, Winn ME, Dykema KJ, Webb CP, MacKeigan JP, Duesbery NS, Nickoloff BJ, Monks NR.
Monsma DJ, et al. Among authors: mackeigan jp.
Am J Cancer Res. 2015 Mar 15;5(4):1507-18. eCollection 2015.
Am J Cancer Res. 2015.
PMID: 26101714
Free PMC article.